Our customers are proven pioneers. Click right to hear how PreciseInhale® helps them.
King’s College London Professor Ben Forbes describes how PreciseInhale® helps his team get better, more relevant results.
Karolinska Institutet Assoc. Professor Lena Palmberg explains how PreciseInhale® can mimic particles in the lungs so closely.
Karolinska Institutet Assistant Professor Swapna Upadahyay emphasizes precision dosing, explaining how the system can dose even nanoparticles precisely.
Chiesi is one of Italy’s leading pharmaceutical companies, and a major developer of inhalation products. Chiesi uses PreciseInhale® to characterize the pharmacokinetic properties of Drug Candidates in the early stages of developing drugs.
Karolinska Institutet is highly successful in the field of environmental research, it uses PreciseInhale® to expose cells for, for example nanoparticles, in its research into new types of airborne pollutants.
King’s College London is a prestigious university widely considered a leader in inhalation research. Professor Ben Forbes’s research team at the University’s Institute of Pharmaceutical Science uses PreciseInhale® to help maintain their position as pioneers in the field.
Fraunhofer ITEM (Institute for Toxicology and Experimental Medicine) is one of the world’s leading institutes in environmental research. Fraunhofer ITEM uses PreciseInhale®, among other technologies, to perform high-quality cell exposures.
Dow chemicals is one of the world’s largest chemical groups. Dow continuously works to understand, measure and map any health risks associated with new types of material, PreciseInhale® is an important tool in this work.